Company profile
OMEICOS Therapeutics GmbH
Developing 1st-in-class therapeutics based on the profound understanding of omega-3 fatty acid metabolism
- Industry
- Biotechnology Research
- Employees
- 9
- Headquarters
- Berlin
- Founded
- 2013
- Office locations
- 2
OMEICOS Therapeutics GmbH company summary
OMEICOS Therapeutics GmbH is a company in the Biotechnology Research industry, headquartered in Berlin, founded in 2013. On LinkedIn the company has around 9 employees. The company lists 2 office locations. Its listed specialties include Drug development, Cardiovascular Research, Mitochondrial Health.
What technology does OMEICOS Therapeutics GmbH use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About OMEICOS Therapeutics GmbH
OMEICOS Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-OPTION Phase 2a clinical study is evaluating OMEICOS’ lead development program OMT-28 in patients with Primary Mitochondrial Disease.
Specialties
Where is OMEICOS Therapeutics GmbH located?
OMEICOS Therapeutics GmbH lists 2 office locations.
Compare companies similar to OMEICOS Therapeutics GmbH
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
OMEICOS Therapeutics GmbH omeicos.com | Biotechnology Research | 9 | 2013 | Berlin |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about OMEICOS Therapeutics GmbH
What does OMEICOS Therapeutics GmbH do?
OMEICOS Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-OPTION Phase 2a clinical study is evaluating OMEICOS’ lead development program OMT-28 in patients with Primary Mitochondrial Disease.
How many employees does OMEICOS Therapeutics GmbH have?
OMEICOS Therapeutics GmbH has around 9 employees on LinkedIn.
Where is OMEICOS Therapeutics GmbH headquartered?
OMEICOS Therapeutics GmbH is headquartered in Berlin.
Where does OMEICOS Therapeutics GmbH have offices?
OMEICOS Therapeutics GmbH lists 2 office locations, including Berlin, 13125, DE; Cambridge, MA, US.
When was OMEICOS Therapeutics GmbH founded?
OMEICOS Therapeutics GmbH was founded in 2013.
Build a lead list from companies like OMEICOS Therapeutics GmbH
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.